Key result
F-actin depolymerizing factor of human serum was purified 250-400-fold to >98% purity, with a recovery of 20-30% and an activity yield of 5-17%.
This study describes a highly reproducible method for purifying F-actin-depolymerizing factor from human serum to over 98% purity.
Answers are grounded in this paper and cite their sources.
Enables mechanistic studies of serum F-actin dynamics; leaves open clinical relevance pending human validation.
F-actin depolymerizing factor (ADF) of human serum was purified 250-400-fold to more than 98% purity with high reproducibility. The purification included (1) 30-50% (NH4)2SO4 precipitation, (2) ion-exchange chromatography on DEAE-Sepharose, (3) chromatofocusing on Polybuffer exchanger 94 and (4) affinity chromatography on ConA-Sepharose. The recovery of ADF was estimated to be 20-30% whereas the ADF activity yield was 5-17%. The lower activity yield was thought to be due-partly to proteolysis and partly to destabilization of highly purified ADF.
No takes yet. Share an insight, caveat, or question.
Thorstensson et al. (2008) studied this question. Purification protocol was evaluated on Purity and recovery of ADF. F-actin depolymerizing factor of human serum was purified 250-400-fold to >98% purity, with a recovery of 20-30% and an activity yield of 5-17%.
Synapse has enriched 10 related papers. Consider them for comparative context: